Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |